Health Insights
Page 2 of 3.
01Articles
- Cancer Awareness Chemotherapy: Myths vs. Facts Don't let fear guide your decisions. We debunk common myths about chemotherapy and explain how modern treatments have improved patient quality of life.
- Prevention & Screening Early Warning Signs of Cancer You Shouldn't Ignore Knowing the early signs of cancer can make a critical difference in treatment outcomes. Discover the key symptoms you should never ignore.
- Treatment Options Understanding Immunotherapy: A New Era in Cancer Treatment Immunotherapy is revolutionizing cancer care by using the body's own immune system to fight tumors. Learn how it works and who can benefit.
- Cancer Awareness Microwave Ovens & Cancer: Myths vs. Scientific Facts Microwave ovens use non-ionizing radiation that cannot damage DNA, and major health bodies find no cancer link. Microwaving can even preserve nutrients better.
- Prevention & Screening More Than One-Third of Cancer Cases Are Preventable Cancer often feels random, but decades of research show over one-third of cases are preventable. Learn the modifiable risk factors behind 30-40% of cancers worldwide.
- Patient Care & Lifestyle Understanding Cancer Recurrence: A Clinical and Strategic Perspective Cancer recurrence is the return of cancer after remission, driven by residual microscopic disease. Many solid tumours peak in risk within 2-5 years of treatment.
- Treatment Options Precision Oncology 2026: Moving from One-Size-Fits-All to One-Size-Fits-One The I-PREDICT trial in the Journal of Clinical Oncology proves N-of-1 precision oncology works: 95% of 210 patients had a unique tumour DNA profile, requiring 157 tailored regimens.
- Research & Insights Nasal Drops May Offer a Non-Invasive Strategy to Fight Brain Tumors Nasal drops carrying gold nanoparticle-based immunotherapy reached brain tumours in preclinical glioblastoma models, bypassing the blood-brain barrier and suppressing tumour growth.
- Research & Insights New Insight into Prostate Cancer: Targeting Two Enzymes May Improve Treatment Outcomes A new study identifies two enzymes, PDIA1 and PDIA5, that help prostate cancer survive and resist treatment. Inhibiting them destabilised the androgen receptor and killed cancer cells.
- Research & Insights Understanding a New Breakthrough in Lung Cancer Research Clone copy number diversity measures how much the clones inside a lung tumour differ in their DNA. Higher diversity is linked to poorer outcomes, and the ALPACA tool maps these changes.